Tfg Advisers LLC Abb Vie Inc. Transaction History

Tfg Advisers LLC

$274 Million
Q3 2024

A detailed history of Tfg Advisers LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tfg Advisers LLC holds 20,719 shares of ABBV stock, worth $4.22 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

20,719

Previous 20,926 0.99%

Holding current value

$4.22 Million

Previous $3.59 Million 13.99%

% of portfolio

1.49%

Previous 1.41%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $33,914 - $41,261	-207 Reduced 0.99%	20,719 $4.09 Million
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $12,692 - $14,822	82 Added 0.39%	20,926 $3.59 Million
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $46,187 - $52,626	289 Added 1.41%	20,844 $3.8 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $67,011 - $75,470	487 Added 2.43%	20,555 $3.19 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $94,448 - $109,337	707 Added 3.65%	20,068 $2.99 Million
Q2 2023 Jul 19, 2023	BUY	$132.51 - $164.9 $69,965 - $87,067	528 Added 2.8%	19,361 $2.61 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $158,492 - $182,527	1,096 Added 6.18%	18,833 $3 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $140,108 - $168,026	1,013 Added 6.06%	17,737 $2.87 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $192,591 - $220,889	1,435 Added 9.39%	16,724 $2.25 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $92,205 - $117,223	670 Added 4.58%	15,289 $2.34 Million
Q1 2022 Apr 20, 2022	BUY	$131.98 - $163.75 $32,863 - $40,773	249 Added 1.73%	14,619 $2.37 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $38,782 - $49,070	361 Added 2.58%	14,370 $1.95 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $10,959 - $12,440	103 Added 0.74%	14,009 $1.51 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $13,046 - $14,534	-124 Reduced 0.88%	13,906 $1.57 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $39,487 - $43,471	386 Added 2.83%	14,030 $1.52 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $44,752 - $60,420	556 Added 4.25%	13,644 $1.46 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $99,483 - $116,761	1,158 Added 9.71%	13,088 $1.15 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $65,372 - $87,478	891 Added 8.07%	11,930 $1.17 Million
Q1 2020 Apr 24, 2020	BUY	$64.5 - $97.79 $23,736 - $35,986	368 Added 3.45%	11,039 $841,000
Q4 2019 Mar 16, 2020	BUY	$72.13 - $90.25 $10,603 - $13,266	147 Added 1.4%	10,671 $944,000
Q3 2019 May 01, 2020	SELL	$62.98 - $75.72 $3,967 - $4,770	-63 Reduced 0.6%	10,524 $796,000
Q2 2019 May 01, 2020	SELL	$65.7 - $83.98 $5,058 - $6,466	-77 Reduced 0.72%	10,587 $769,000
Q1 2019 Apr 30, 2020	BUY	$77.14 - $90.79 $76,137 - $89,609	987 Added 10.2%	10,664 $859,000
Q4 2018 Apr 29, 2020	BUY	$77.85 - $96.01 $753,354 - $929,088	9,677 New	9,677 $892,000

Others Institutions Holding ABBV

# of Institutions

3,771

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Advisers LLC with notifications on news.

Account